Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$381.61 USD

381.61
1,013,282

+8.28 (2.22%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $381.63 +0.02 (0.01%) 4:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (61 out of 244)

Industry: Medical - Hospital

Zacks News

Zacks Equity Research

Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Zacks Equity Research

Avantor, Inc. (AVTR) Hits Fresh High: Is There Still Room to Run?

Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Why Should You Add Universal Health (UHS) to Your Portfolio?

Backed by its strategic measures, solid segmental contributions and a strong solvency level, Universal Health (UHS) holds potential to reap benefits for investors.

Zacks Equity Research

Tenet Healthcare (THC) Expands Its Relationship With Cigna

Tenet Healthcare (THC) stretches multi-year contract with Cigna to provide its in-network access to the latter's customers.

Zacks Equity Research

Cigna (CI) Extends Tie-Up to Offer Better Care in Connecticut

Cigna (CI) extends relationship with Hartford HealthCare to jointly offer enhanced healthcare services and thus, better health outcomes in Connecticut.

Zacks Equity Research

Acadia Healthcare (ACHC) Soars to 52-Week High, Time to Cash Out?

Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Encompass Health (EHC) Opens Hospital, Boosts Florida Footprint

Encompass Health (EHC) opens an inpatient rehabilitation hospital in Pensacola, FL aimed at providing improved health outcomes across the state.

Shilpa Mete headshot

5 GARP Stocks to Scoop Up for Maximum Returns

If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

Zacks Equity Research

New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Universal Health Services, Acadia Healthcare Co, HCA Healthcare and Tenet Healthcare

The Zacks Analyst Blog Highlights: Universal Health Services, Acadia Healthcare Co, HCA Healthcare and Tenet Healthcare

Zacks Equity Research

The Zacks Analyst Blog Highlights: Broadcom, BlackRock, HCA Healthcare, Johnson Controls and Equity Residential

The Zacks Analyst Blog Highlights: Broadcom, BlackRock, HCA Healthcare, Johnson Controls and Equity Residential

Zacks Equity Research

HCA Healthcare (HCA) Hits 52 Week High: More Room for Upside?

HCA Healthcare's (HCA) shares soar as investors get optimistic about its strategic initiatives and recovering volumes.

Sheraz Mian headshot

Top Stock Reports for Broadcom, BlackRock & HCA Healthcare

Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), BlackRock, Inc. (BLK), and HCA Healthcare, Inc. (HCA).

Debasmita Chatterjee headshot

4 Hospital Stocks Likely to Perform Well in 2H21

Companies like UHS, ACHC, HCA and THC are well-poised to gain in the second half of 2021 as the hospital industry is expected to benefit from rebounding admissions and continuous M&A activities.

Zacks Equity Research

Here's Why Investors Should Hold on to Ensign Group (ENSG)

Riding high on a bright 2021 guidance, strategic initiatives and a robust portfolio, Ensign Group (ENSG) holds potential to reap benefits for investors.

Zacks Equity Research

HCA (HCA) Down 2.7% Since Last Earnings Report: Can It Rebound?

HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Tenet Healthcare (THC) Announces Partial Redemption of Notes

To boost financial flexibility, Tenet Healthcare (THC) announces partial redemption of senior secured notes to procure funds for paying down its future annual cash interest payments.

Zacks Equity Research

Here's Why You Should Invest in Encompass Health (EHC) Now

Encompass Health (EHC) is riding on top-line growth, higher patient volumes, continuous facility expansions and reducing debt levels.

Zacks Equity Research

Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Zacks Equity Research

Here's How Much a $1000 Investment in HCA Healthcare Made 10 Years Ago Would Be Worth Today

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Urmimala Biswas headshot

6 Lucrative PEG Picks Based on Hybrid Investment Strategy

Here are six GARP stocks, ACI, CAR, TX, CLS, HCA, and ARCB based on discounted PEG.

Zacks Equity Research

MEDNAX's (MD) Earnings Beat Estimates in Q2, Improve Y/Y

MEDNAX's (MD) Q2 results reflect solid volumes, partly offset by escalating expenses.

Zacks Equity Research

Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Sapna Bagaria headshot

3 Hospital Stocks to Buy as the Top-Ranked Industry Rebounds

Stocks in the hospital industry look set to grow on the back of higher patient admissions.

Zacks Equity Research

Select Medical (SEM) Q2 Earnings Beat, Raises '21 EPS View

Select Medical's (SEM) second-quarter results reflect strong top-line growth, higher admissions and increased patient visits, partly offset by elevated costs.